< Back to companies
Nemaura Medical

Nemaura Medical

Loughborough, United Kingdom

Nemaura Medical Inc. is a medical technology company developing and commercializing non-invasive wearable diagnostic devices. The company is currently commercializing sugarBEAT®, BEAT™diabetes, and proBEAT™. sugarBEAT®, a CE mark approved Class IIb medical device, is a non-invasive and flexible continuous glucose monitor (CGM) providing actionable insights derived from real time glucose measurements and daily glucose trend data, which may help people with diabetes and pre-diabetes to better manage, reverse, and prevent the onset of diabetes. Nemaura has submitted a PMA (Premarket Approval Application) for sugarBEAT® to the U.S. FDA. proBEAT™ combines non-invasive glucose monitoring with artificial intelligence and a digital healthcare subscription service, and is expected to be launched in the U.S. as a general wellness product.

Only accessible to MedStartr community members. Join now

Company Info

Founded
2018
Website
nemauramedical.com/

Categories

DiagnosticsWearables

Disease Areas

Technologies

Wearable DevicesNon-Invasive DiagnosticsDiagnostic DevicesMedical Devices
Only accessible to MedStartr community members. Join now

What do you think of Nemaura Medical?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Innovation

Clinical Benefit

Feasibility

Scalability

Only accessible to MedStartr community members. Join now